These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Advantages and inconveniences of inactive and live antipoliomyelitis vaccines]. Melnick JL. Bull World Health Organ; 1978; 56(5):677-98. PubMed ID: 310715 [No Abstract] [Full Text] [Related]
14. [Poliomyelitis vaccination in Denmark]. Petersen I. Ugeskr Laeger; 1985 Jan 21; 147(4):265-9. PubMed ID: 3976028 [No Abstract] [Full Text] [Related]
15. [Problems of prevention and control of poliomyelitis in Poland]. Mazurowska-Magdzik W, Bucholc B, Janaszek-Seydlitz W, Szkoda T, Magdzik W. Przegl Epidemiol; 2010 Jan 21; 64(3):341-7. PubMed ID: 20976944 [Abstract] [Full Text] [Related]
17. [Vaccination against poliomyelitis. Formation of immunity evaluated according to the results of serological surveys]. Zabicka J. Przegl Epidemiol; 1981 Jan 21; 35(3):385-9. PubMed ID: 6276928 [No Abstract] [Full Text] [Related]
18. [International practice of immunization (vaccination against poliomyelitis)]. Libov AL. Zh Mikrobiol Epidemiol Immunobiol; 1970 Nov 21; 47(11):134-7. PubMed ID: 5505306 [No Abstract] [Full Text] [Related]